Skip to content
Screener

Exelixis EXEL Total Current Liabilities

Total Current Liabilities at other companies

Eli Lilly logo
Eli LillyLLY
$47.74B+22.4%
Pfizer logo
PfizerPFE
$34.35B-5.8%
Kura Oncology logo
Kura OncologyKURA
$101.5M+13.1%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$14.33M-60.1%
Immunome logo
ImmunomeIMNM
$27.41M-11.0%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$198M-5.7%

Other financials

Income statement

See full
Revenue$628.7M+10.6%
Gross profit$608.0M+10.8%
Operating income$248.4M+16.3%
Net income$212.1M+14.7%
EPS (diluted)$0.82+26.2%

Balance sheet

See full
Cash & equivalents$281.4M+71.2%
Total debt$165.9M-7.7%
Total equity$1.8B-9.3%
Total assets$2.5B-6.9%

Cash flow

See full
Operating cash flow$307.7M+528%
CapEx$6.8M+140%
Free cash flow$300.9M+552%

Valuation

See full
Market cap$14.25B+40.4%
Enterprise value$14.14B+39.0%
P/E16.6×-0.3×
P/S5.9×+1.3×

Profitability

See full
Gross margin96.5%-0.1pp
Operating margin39.9%+8.5pp
Net margin35.3%+8.3pp
FCF margin48.1%+14.3pp

Returns & leverage

See full
Return on equity44.4%+15.4pp
Debt / equity0.1×0.0×
Current ratio3.5×-0.1×

Where this comes from

Reported directly by Exelixis in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The source filing: Exelixis’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:13 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q3 2026
Accession
0000939767-26-000098
Line itemJune 30, 2026December 31, 2025
Rebates and fees due to customers66,71159,896
Accrued collaboration liabilities25,09622,783
Other current liabilities102,662125,382
Total current liabilities361,927405,644
Non-current operating lease liabilities165,929173,038
Other non-current liabilities122,616104,422
Total liabilities650,472683,104
Commitments and contingencies (Note 11)

Item 1. Financial Statements.

FAQ

What is Exelixis's total current liabilities?
Exelixis (EXEL) reported total current liabilities of $361.93M in Q2 2026.
How has Exelixis's total current liabilities changed year-over-year?
Exelixis's total current liabilities increased by 7.7% year-over-year, from $336.11M to $361.93M.
What is the long-term trend for Exelixis's total current liabilities?
Over 5 years (2020 to 2025), Exelixis's total current liabilities has grown at a 14.7% compound annual growth rate (CAGR), from $204.66M to $405.64M.
What does total current liabilities mean?
The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.

Ask your AI about Exelixis's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude